Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Invested Capital of $630.0 million for Q1 2026, up 41.57% year-over-year from $445.0 million in Q1 2025, and up 41.57% quarter-over-quarter from $445.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Invested Capital history runs 18 years deep, the most recent figure standing at $630.0 million for Q1 2026.
- In Q1 2026, Invested Capital rose 41.57% year-over-year to $630.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 43.32% YoY), while the FY2026 annual figure was $630.0 million, up 41.57% from the prior year.
- Invested Capital for Q1 2026 stood at $630.0 million, up from $445.0 million in the prior quarter.
- The five-year high for Invested Capital was $630.0 million in Q1 2026, with the low at $13.0 million in Q1 2022.
- The 5-year median for Invested Capital is $254.0 million (2023), against an average of $258.9 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital tumbled 93.7% in 2024, then jumped 2681.25% in 2025.
- Dr Reddys Laboratories' Invested Capital stood at $301.0 million in 2022, then slumped by 49.17% to $153.0 million in 2023, then plunged by 89.54% to $16.0 million in 2024, then surged by 2681.25% to $445.0 million in 2025, then soared by 41.57% to $630.0 million in 2026.
- Business Quant data shows RDY's Invested Capital at $630.0 million in Q1 2026, $445.0 million in Q1 2025, and $16.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.00 Mn |
| Mar 31, 2025 | 445.00 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Jun 30, 2023 | 153.00 Mn |
| Mar 31, 2023 | 254.00 Mn |
| Jun 30, 2022 | 301.00 Mn |
| Mar 31, 2022 | 13.00 Mn |
| Mar 31, 2021 | 12.00 Mn |
| Dec 31, 2020 | 280.00 Mn |
| Sep 30, 2020 | 376.00 Mn |
| Mar 31, 2020 | 57.00 Mn |
| Dec 31, 2019 | 224.00 Mn |
| Sep 30, 2019 | 442.00 Mn |
| Mar 31, 2019 | 62.00 Mn |
| Dec 31, 2018 | 614.00 Mn |
| Jun 30, 2018 | 793.00 Mn |
| Mar 31, 2018 | 742.00 Mn |
| Dec 31, 2017 | 860.00 |
| Sep 30, 2017 | 841.00 |
| Jun 17, 2017 | 781.00 Mn |